MarketPeel
Insider Trading Intelligence
Pricing
…
JL

Jiangsu Hengrui Pharmaceuticals Co., Ltd.

KLRA
10% OWNER · KAILERA THERAPEUTICS, INC. · CIK 0002080343
FILING MIX · LIFETIME50%/50%
BUYS
2
SELLS
2
TOTAL VALUE
$0
COMPANIES
1
ACTIVE SINCE
Apr 2026
HOLDINGS NOW
0
AVG SELL PX
—
TRADE KIND
SHOWING 4 / 4
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Jiangsu Hengrui Pharmaceuticals Co., Ltd.. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
KLRA · 0 shares · as of Apr 20, 2026
02,369,4304,738,8607,108,2899,477,719SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2026
FLOW · 2 buys / 2 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
KLRA
KAILERA THERAPEUTICS, INC.
PURCHASE
2,034,133——2,034,133Apr 20, 2026Apr 22, 2026 ↗View →
KLRA
KAILERA THERAPEUTICS, INC.
SALE
708,814——0Apr 20, 2026Apr 22, 2026 ↗View →
KLRA
KAILERA THERAPEUTICS, INC.
PURCHASE
9,477,719——9,477,719Apr 20, 2026Apr 22, 2026 ↗View →
KLRA
KAILERA THERAPEUTICS, INC.
SALE
4,968,789——0Apr 20, 2026Apr 22, 2026 ↗View →
Other insiders · KLRA
Loading peer insiders…
About this filer
CIK 0002080343
ROLE
10% Owner
PRIMARY
KLRA
COMPANIES
1
ACTIVE SINCE
Apr 2026
MARKETPEEL · /INSIDER/0002080343DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback